Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Mar 8;55(1):1295–1303. doi: 10.1080/13880209.2017.1299768

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/Licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 1. — Effect of CEL and its combination with FA on SBP. *p < 0.05 CEL + FA (3rd and 4th weeks) vs. Baseline, ***p < 0.001 CEL (3rd and 4th weeks) vs. Baseline; DOX (3rd week) vs. Baseline; and CEL + DOX (3rd week) vs. Baseline. †p < 0.05 CEL + FA (3rd week) vs. CEL, CEL + DOX (4th week) vs. DOX; ††p < 0.01 CEL (2nd week) vs. Control, †††p < 0.001 CEL (3rd and 4th weeks) vs. Control; CEL + FA (4th week) vs. CEL; DOX (3rd week) vs. Control; CEL + DOX (3rd week) vs. DOX; and CEL + FA + DOX (3rd and 4th weeks) vs. CEL + DOX. DOX: Doxorubicin; CEL: Celecoxib; FA: Folic acid; SBP: systolic blood pressure.